Literature DB >> 19610597

Docking and 3D-QSAR studies on isatin sulfonamide analogues as caspase-3 inhibitors.

Qi Wang1, Robert H Mach, David E Reichert.   

Abstract

To provide insight of their inhibition mechanism and facilitate the design of more potent ligands, a series of 59 isatin sulfonamide analogues were docked to the X-ray structure of caspase-3, one of the important cysteine aspartyl-specific execution proteases in apoptosis, and their binding conformations were analyzed by 3D-QSAR studies. Comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA) studies suggest that both steric and electrostatic interactions contribute to the compounds' binding affinity, with the major contribution arising from hydrophobic interactions. The models show excellent correlation and high predictive power even evaluated by the most stringent criteria for a QSAR model. The results of this work demonstrate that structure-based design methods (such as docking) cultivate the development of reliable QSAR models; they also illustrate the utility of this procedure in design of new potent caspase-3 ligands.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19610597      PMCID: PMC2767110          DOI: 10.1021/ci900144x

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  32 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Conformational restrictions in the active site of unliganded human caspase-3.

Authors:  Chao-Zhou Ni; Chenglong Li; Joe C Wu; Alfred P Spada; Kathryn R Ely
Journal:  J Mol Recognit       Date:  2003 May-Jun       Impact factor: 2.137

3.  Rational selection of training and test sets for the development of validated QSAR models.

Authors:  Alexander Golbraikh; Min Shen; Zhiyan Xiao; Yun-De Xiao; Kuo-Hsiung Lee; Alexander Tropsha
Journal:  J Comput Aided Mol Des       Date:  2003 Feb-Apr       Impact factor: 3.686

Review 4.  Development of quantitative structure-activity relationships and its application in rational drug design.

Authors:  Guang-Fu Yang; Xiaoqin Huang
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

5.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation.

Authors:  G Jones; P Willett; R C Glen
Journal:  J Mol Biol       Date:  1995-01-06       Impact factor: 5.469

6.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

7.  A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury.

Authors:  Justin G Chapman; William P Magee; Hans A Stukenbrok; Gretchen E Beckius; Anthony J Milici; W Ross Tracey
Journal:  Eur J Pharmacol       Date:  2002-12-05       Impact factor: 4.432

8.  Potent and selective nonpeptide inhibitors of caspases 3 and 7.

Authors:  D Lee; S A Long; J H Murray; J L Adams; M E Nuttall; D P Nadeau; K Kikly; J D Winkler; C M Sung; M D Ryan; M A Levy; P M Keller; W E DeWolf
Journal:  J Med Chem       Date:  2001-06-07       Impact factor: 7.446

Review 9.  Emerging roles of caspase-3 in apoptosis.

Authors:  A G Porter; R U Jänicke
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

10.  Isatin sulfonamide analogs containing a Michael addition acceptor: a new class of caspase 3/7 inhibitors.

Authors:  Wenhua Chu; Justin Rothfuss; André d'Avignon; Chenbo Zeng; Dong Zhou; Richard S Hotchkiss; Robert H Mach
Journal:  J Med Chem       Date:  2007-06-23       Impact factor: 7.446

View more
  5 in total

Review 1.  Small Molecule Active Site Directed Tools for Studying Human Caspases.

Authors:  Marcin Poreba; Aleksandra Szalek; Paulina Kasperkiewicz; Wioletta Rut; Guy S Salvesen; Marcin Drag
Journal:  Chem Rev       Date:  2015-11-09       Impact factor: 60.622

2.  Synthesis and evaluation of isatin analogs as caspase-3 inhibitors: introduction of a hydrophilic group increases potency in a whole cell assay.

Authors:  Wenhua Chu; Justin Rothfuss; Dong Zhou; Robert H Mach
Journal:  Bioorg Med Chem Lett       Date:  2011-04-15       Impact factor: 2.823

3.  Structural requirements of N-substituted spiropiperidine analogues as agonists of nociceptin/orphanin FQ receptor.

Authors:  Pingping Bao; Xiaole Zhang; Hong Ren; Yan Li; Zulin Mu; Shuwei Zhang; Guohui Li; Ling Yang
Journal:  Int J Mol Sci       Date:  2011-12-06       Impact factor: 5.923

Review 4.  Theory and applications of covalent docking in drug discovery: merits and pitfalls.

Authors:  Hezekiel Mathambo Kumalo; Soumendranath Bhakat; Mahmoud E S Soliman
Journal:  Molecules       Date:  2015-01-27       Impact factor: 4.411

5.  Mechanism Exploration of Arylpiperazine Derivatives Targeting the 5-HT2A Receptor by In Silico Methods.

Authors:  Feng Lin; Feng Li; Chao Wang; Jinghui Wang; Yinfeng Yang; Ling Yang; Yan Li
Journal:  Molecules       Date:  2017-06-26       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.